1-1 of 1
Ryutaro Shimazaki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Study to Determine the Optimal Dose of Darbepoetin Alfa in Patients with Low- or Intermediate-1 Risk Myelodysplastic Syndromes

Hironori Harada, MD PhD, Hirohiko Shibayama, Jun Ho Jang, MD PhD, Ryutaro Shimazaki, Kinuko Mitani, MD, PhD, Kenichi Sawada, MD PhD, Hyeoung-Joon Kim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4642.
https://doi.org/10.1182/blood.V124.21.4642.4642
Published: 2014